Conversations with beverage industry executives reveal that the summer months could see a sales surge of around 25-30% y-o-y between March and May.

Indian share market offers excellent investment options for March 2025, and some stocks have great potential to grow in a big ...

Despite low volatility in the domestic stock markets over the past few months, investors are expected to tread cautiously ...

Vishal Mega Mart had as many as 9.13 lakh retail shareholders, or those with authorised share capital of up to ₹2 lakh as of ...

Reliance Consumer Products Ltd (RCPL), the packaged goods arm of Reliance Industries Ltd (RIL), will take three to four years ...

Citi maintained a ‘buy’ rating but cut the target price from Rs 1,350 to Rs 1,160. Nuvama downgraded the stock to ‘reduce’ from ‘hold’, lowering the target price to Rs 750. Emkay downgraded to ‘add’ ...

Brokerage firms remain divided on Zydus Lifesciences as the company announced to acquire France-based Amplitude Surgical for €257 million (Rs 2,500 crore).

Brokerages deemed Zydus Life's acquisition of Amplitude Surgical as expensive, with subpar synergies that has triggered ...

Citi's picks in India's asset management companies are 360 One, Nuvama and Prudent. While Aditya Birla Sun Life AMC Ltd's ...

Nuvama is of the view that the Zydus Life's latest deal would be dilutive to the company's Earnings Per Share (EPS) by 1% to ...

Nuvama cuts Zydus Lifesciences target by 16%, citing weak synergy with Amplitude acquisition. Read more about the financial outlook now!

A number of brokerage firms believe that India equities have turned attractive for the investors after the recent correction ...